Zurueck zur Suche

Reporte zur Charge EN2Y7

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

5Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
OH 3 PA 1 NJ 1

VAERS 2637265

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge EN2Y7

mild
Staat
OH
Alter
1,6
Geschlecht
M
Eingang
26.05.2023
Impfdatum
01.02.2022
Beginn
02.02.2022
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Post vaccination fever Pyrexia

Symptomtext

Fever NOS on 2022-02-02, Postvaccination fever on 2022-02-02.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Post vaccination fever
Hospital-Tage
1,0
Labordaten
-
Aktuelle Erkrankungen
Plagiocephaly; Encounter for routine child health examination NOS
Vorgeschichte
-
Andere Medikamente
None
Allergien
-
Vorherige Impfungen
-

VAERS 2011042

GLAXOSMITHKLINE BIOLOGICALS · HIB (HIBERIX) · Charge EN2Y7

mild
Staat
PA
Alter
1,3
Geschlecht
M
Eingang
06.01.2022
Impfdatum
04.01.2022
Beginn
04.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site rash Rash Rash macular

Symptomtext

One hour after shot red splotchy rash six inches around injection site. By 5pm, matching rash on right leg. By 6pm rash visible on wrists. By 7pm legs covered in rash, upper arms and neck. Monitored all night for breathing okay. The next morning rash spread up entire trunk and around front. Subsided by 10am follow up appointment but still on every area of body during exam. Anti-histimine prescribed. A single 2.5 dose of zyrtex given at noon. Rash still visible on legs, arms and diaper area at bedtime but largely cleared. Faintly visible at follow up next morning at 10am.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Diarrhea
Vorgeschichte
-
Andere Medikamente
None
Allergien
Suspected dairy
Vorherige Impfungen
-

VAERS 2625754

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge EN2Y7

gering
Staat
OH
Alter
0,2
Geschlecht
F
Eingang
03.05.2023
Impfdatum
01.02.2022
Beginn
02.02.2022
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Adverse event

Symptomtext

Adverse effect of other vaccines and biological substances, initial encounter on 2022-02-02.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Nasal congestion; Encounter for routine child health examination NOS; Hemangioma of other sites; Seborrhea capitis; Encounter for routine child health examination NOS
Vorgeschichte
-
Andere Medikamente
None
Allergien
-
Vorherige Impfungen
-

VAERS 2608120

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge EN2Y7

gering
Staat
OH
Alter
1,3
Geschlecht
F
Eingang
03.04.2023
Impfdatum
21.02.2022
Beginn
24.02.2022
Tage bis Beginn
3,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Vaccination complication

Symptomtext

Other complications following immunization, not elsewhere classified, initial encounter on 2022-02-24.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Vaccination complication
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Ankyloglossia; Encounter for routine child health examination NOS; Encounter for screening for genitourinary disorders; Feeding difficulties, unspecified; Ankyloglossia; Encounter for routine child health examination NOS; Singleton, unspecified as to place of birth; Encounter for screening for genitourinary disorders; Encounter for routine child health examination NOS
Vorgeschichte
-
Andere Medikamente
None
Allergien
-
Vorherige Impfungen
-

VAERS 2238277

GLAXOSMITHKLINE BIOLOGICALS · HIB (HIBERIX) · Charge EN2Y7

gering
Staat
NJ
Alter
-
Geschlecht
M
Eingang
18.04.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Circumstance or information capable of leading to medication error Medication error Product prescribing error

Symptomtext

they plan to administer Hiberix to a 37 year old patient; Circumstance or information capable of leading to medication error; This case was reported by a pharmacist via call center representative and described the occurrence of drug prescribing error in a 37-year-old male patient who received Hib (Hiberix) (batch number EN2Y7, expiry date 1st April 2023) for prophylaxis. The patient's past medical history included splenectomy. On an unknown date, the patient did not receive Hiberix. On an unknown date, unknown after receiving Hiberix, the patient experienced drug prescribing error and circumstance or information capable of leading to medication error. On an unknown date, the outcome of the drug prescribing error and circumstance or information capable of leading to medication error were unknown. Additional Information: GSK receipt date: 12-Apr-2022 Reporter's comment: Pharmacist called in to inquired and report about any information over the age of 4 years for Hiberix. The reporter stated they had planned to administer Hiberix to a 37 year old patient on date of reporting (12th April 2022) who had a splenectomy. The reporter asked that it could be administered. Did not consent to follow-up. Additional Supportive Information: The pharmacist planned to administer Hiberix to a 37 year old patient on date of reporting, which led to drug prescribing error and circumstance or information capable of leading to medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Circumstance or information capable of leading to medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Splenectomy
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-